IRIS UniCatt

Di Nardo, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 783
NA - Nord America 720
EU - Europa 467
SA - Sud America 184
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 688
SG - Singapore 385
CN - Cina 206
BR - Brasile 157
SE - Svezia 88
DE - Germania 85
FR - Francia 63
IT - Italia 59
VN - Vietnam 44
GB - Regno Unito 40
IE - Irlanda 33
IN - India 32
FI - Finlandia 30
ID - Indonesia 30
RU - Federazione Russa 21
CA - Canada 20
BD - Bangladesh 17
HK - Hong Kong 16
KR - Corea 14
PL - Polonia 14
ZA - Sudafrica 10
JP - Giappone 9
CI - Costa d'Avorio 7
ES - Italia 7
MX - Messico 7
AR - Argentina 6
EC - Ecuador 6
NL - Olanda 6
PK - Pakistan 6
IQ - Iraq 5
BE - Belgio 4
BO - Bolivia 4
KE - Kenya 4
TR - Turchia 4
AT - Austria 3
JO - Giordania 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
UA - Ucraina 3
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
PT - Portogallo 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
PA - Panama 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.184
Salva come PNG Salva come JPEG
Città #
Singapore 184
Chandler 132
Ashburn 80
Beijing 46
Hefei 46
Dallas 34
Dublin 33
New York 28
Jakarta 27
Helsinki 20
Los Angeles 19
Milan 19
The Dalles 19
Frankfurt am Main 18
Boston 17
Bremen 17
Kent 17
Munich 17
Ho Chi Minh City 16
Hong Kong 16
Moscow 15
Rome 14
Seoul 14
Chicago 13
Princeton 12
London 11
São Paulo 11
Warsaw 11
Hyderabad 10
Redwood City 10
Düsseldorf 9
Hanoi 9
North Bergen 9
San Mateo 9
Atlanta 8
Nuremberg 8
Tokyo 8
Wilmington 8
Abidjan 7
Lauterbourg 7
Stockholm 7
Ottawa 6
Boardman 5
Johannesburg 5
Lappeenranta 5
Montreal 5
Pune 5
Turku 5
Amsterdam 4
Boydton 4
Brooklyn 4
Brussels 4
Buffalo 4
Falkenstein 4
Mexico City 4
Nairobi 4
Orem 4
Paris 4
Portsmouth 4
Roubaix 4
Santa Clara 4
Toronto 4
Amman 3
Araraquara 3
Baghdad 3
Bologna 3
Campinas 3
Can Tho 3
Chennai 3
Council Bluffs 3
Denver 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Manchester 3
Mumbai 3
Nova Iguaçu 3
Porto Alegre 3
Ribeirão das Neves 3
Rio de Janeiro 3
Salvador 3
Southampton 3
Ajax 2
Baku 2
Bauru 2
Belo Horizonte 2
Betim 2
Bexley 2
Bắc Giang 2
Campo Grande 2
Chittagong 2
City of London 2
Cleveland 2
Edinburgh 2
Houston 2
Indaiatuba 2
Joinville 2
Juiz de Fora 2
La Paz 2
Lima 2
Totale 1.203
Salva come PNG Salva come JPEG
Nome #
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 112
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 107
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 90
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 89
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 89
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 80
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 79
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 78
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 78
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 78
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 76
Molecular alterations in basal cell carcinoma subtypes 74
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 73
Understanding the molecular genetics of basal cell carcinoma 73
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 72
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 71
Familial Melanoma: Diagnostic and Management Implications 69
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab 67
Intra-patient heterogeneity of BRAF and NRAS molecular alterations in primary melanoma and metastases 64
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 63
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 61
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study 61
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 60
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 60
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 59
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 57
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies 57
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 52
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 49
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 46
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 45
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review 25
Totale 2.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 24 2 1 1 0 2 0
2021/202283 1 1 1 6 7 1 1 10 3 7 21 24
2022/2023338 36 44 26 62 28 36 11 32 39 6 11 7
2023/2024261 7 46 27 34 16 28 9 8 9 6 36 35
2024/2025630 10 2 43 12 58 30 24 18 71 74 156 132
2025/2026859 228 70 127 207 218 9 0 0 0 0 0 0
Totale 2.214